DGAP-News: SphingoTec GmbH: New diagnostic tool for the management of patients with sepsis: Dipeptidyl Peptidase 3 (DPP3) boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.
(1)
Researchers have published new insights into the causes of mortality in sepsis
Loss of endothelial function is induced through two different pathophysiological processes and is a major driver of septic shock, a life-threatening drop in blood pressure
The first pathway originates in the loss of the endothelial barrier triggering an increased production of the repair hormone bioactive Adrenomedullin (bio-ADM), which also has the undesired side effect of vasodilation
The second threat acting on the endothelial function is the release of the protease DPP3 into the bloodstream which degrades angiotensin II, a process resulting in decreased vascular tone and cardiac output
DGAP-News: Proen .
DGAP-News: Proenkephalin (penKid(R)) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients
vom 16.12.2020, 10:00 Uhr
Bild: pixabay.com
DGAP-News: SphingoTec GmbH / Key word(s): Scientific publication/Statement
Proenkephalin (penKid(R)) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients
16.12.2020 / 10:00
The issuer is solely responsible for the content of this announcement.
The latest consensus meeting of international experts in critical care and nephrology supports the use of novel biomarkers in the prevention and management of Acute Kidney Injury (AKI)
The consensus recommends using a combination of damage and functional biomarkers together with clinical information for routine practice
Press release content from Accesswire. The AP news staff was not involved in its creation.
Proenkephalin (penKid(R)) Included in the ADQI Consensus Statements Publication as Functional Kidney Biomarker for the Management of AKI Patients
December 16, 2020 GMT
The latest consensus meeting of international experts in critical care and nephrology supports the use of novel biomarkers in the prevention and management of Acute Kidney Injury (AKI)
The consensus recommends using a combination of damage and functional biomarkers together with clinical information for routine practice
Proenkephalin (penKid(R)), the kidney function biomarker, proposed as a marker for the assessment of AKI progression and kidney recovery